Abstract
Anti-depressant drugs have now been available for a quarter of a century. Historically the two main categories of antidepressants, the monoamine oxidase (MAO) inhibitors and the imipramine-1ike drugs, were discovered by serendipity in the clinic.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
E. B. Sigg, Pharmacological studies with tofranil, Canad. psychiat. Ass. J. 4: 75 (1959).
W. Haefely, A. Hlirlimann, and H. Thoenen, Scheinbar paradoxe Beeinflussung von peripheren Noradrenalin-Wirkungen durch einige Thymoleptica, Helv. Physiol. Pharmacol. Acta 22: 15 (1964).
W. Haefely, M.-A. Ruch-Monachon, M. Jalfre, and R. Schaffner, Interaction of psychotropic agents with central neurotransmitters as revealed by their effects on PGO waves in the cat, Drug Research26: 1036 (1976).
G.W. Vogel, Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs, Progr. Neuropsychopharmacol. & Biol. Psychiat. 7: 343 (1983).
F. Sulser, New perspectives on the mode of action of antidepressant drugs, Trends in Pharmacological Sciences1: 92 (1979).
D.J. Woodward, H.C. Moises, B.D. Waterhouse, B.J. Hoffer, and R. Freedman, Modulatory actions of norepinephrine in the central nervous system, Fed. Proc. 38: 2109 (1979).
P. Pole, J. Schneeberger, and W. Haefely, Effects of several centrally active drugs on the sleep-wakefulness cycle of cats, Neuropharmacology18: 259 (1979).
R. Scherschlicht, P. Pole, J. Schneeberger, M. Steiner, and W. Haefely, Selective suppression of rapid eye movement sleep (REMS) in cats by typical and atypical antidepressants, in: “Typical and atypical antidepressants: molecular mechanisms,” E. Costa and G. Racagni, eds., Raven Press, New York (1982).
M. Da Prada, H.H. Keller, W.P. Burkard, R. Schaffner, E.P. Bonetti, J.M. Launay, and W. Haefely, Some neuropharmacological effects of Ro 11–2465 — a novel tricyclic antidepressant with potent inhibitory activity on the uptake of 5-HT, in: “Typical and atypical antidepressants: molecular mechanisms”, E. Costa and G. Racagni, eds., Raven Press, New York (1982).
H.H. Keller, R. Schaffner, M.D. Carruba, W.P. Burkard, M. Pieri, E.P. Bonetti, R. Scherschlicht, M. Da Prada, and W.E. Haefely, Diclofensine (Ro 8–4650) — a potent inhibitor of monoamine uptake: biochemical and behavioural effects in comparison with nomifensine, in; “Typical and atypical antidepressants: molecular mechanisms”, E. Costa and G. Racagni, eds., Raven Press, New York, (1982).
M. Da Prada, R. Kettler, H.H. Keller, and W.E. Haefely, Neurochemical effects in vitro and in vivo of the antidepressant Ro 11–1163, a specific and short-acting MAO-A inhibitor. Mod. Probi. Pharmacopsychiat. 19: 231 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer Science+Business Media New York
About this chapter
Cite this chapter
Haefely, W. (1985). Preclinical Pharmacology of Antidepressants. In: Pichot, P., Berner, P., Wolf, R., Thau, K. (eds) Biological Psychiatry, Higher Nervous Activity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8329-1_15
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8329-1_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8331-4
Online ISBN: 978-1-4684-8329-1
eBook Packages: Springer Book Archive